Summary Oncogenex Pharmaceuticals Inc (OncoGenex) formerly known as Sonus Pharmaceuticals Inc, is a drug discovery and development company that develops and commercializes therapies and mechaisms for addressing treatment resistance in cancer patients. The company’s products include custirsen and apatorsen. Its custirsen drug is designed to block the production of clusterin, a cytoprotective protein which is upregulated in tumor cells in response to treatment interventions such as chemotherapy...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.